Showing results 1 to 2 of 2
| Title | Author(s) | Issue Date | |
|---|---|---|---|
HBV PGRNA and DNA both rebound immediately following discontinuation of the core inhibitor vebicorvir despite continued nrti treatment in patients with HBeAg positive chronic hepatitis B virus infection: findings from a phase 2 open label study Proceeding/Conference:Oral presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology | 2021 | ||
| 2021 |